In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

India Takes Steps To End Branded Drug Name Confusion

This article was originally published in PharmAsia News

Executive Summary

Indian authorities plan to establish a licensing board to approve names applied to branded drugs to end confusion over medicines with similar names. The Drug Controller General of India approves drugs marketed in the country, but names come under the authority of the Trade Marks Act and are licensed on the state level. The new licensing authority would be part of a broader plan to move manufacturing authority from the state to the federal level and a central agency. The chemical and health ministries already have given their approval to the proposed rearrangement. (Click here for more
Advertisement
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC069502

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel